REGULATION OF POSTNATAL CORTICAL MULTIPOTENT PROGENITORS
产后皮质多能祖细胞的调节
基本信息
- 批准号:6394170
- 负责人:
- 金额:$ 29.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:cell cell interaction cell differentiation cell growth regulation cell proliferation cell transplantation cerebral cortex developmental neurobiology epidermal growth factor fluorescence microscopy glia immunocytochemistry laboratory rat neurogenesis neurons neurotrophic factors newborn animals oligodendroglia stem cells
项目摘要
We have isolated multipotent progenitor cells from the cerebral cortex
independent of periventricular generative zones during the peak period
of early postnatal gliogenesis. These progenitor species undergo
cellular expansion and self-renewal in vitro in response to epidermal
growth factor and can generate neurons and glia, including myelin
protein-expressing oligodendrocytes. Glial progenitors derived from
these multipotent progenitors express the neurotrophin-3 receptor, trkC,
and application of neurotrophin-3 selectively promotes the expansion of
oligodendrocyte progenitors that require additional environmental
signals (ciliary neurotrophic factor, CNTF) for oligodendrocyte
differentiation. Neurotrophin-3 can also induce the expression of the
CNTFalpha receptor on glial progenitors derived from cortical
multipotent cells, while bone morphogenetic proteins promote the
generation of astrocytes and induce the expression of trkC on these
progenitor species. In preliminary in vivo studies, we have also shown
that transplanted cortical multipotent cells can undergo cellular
expansion and give rise to glial and neuronal progeny. In addition,
glial progenitors isolated from these multipotent cells proliferate in
vivo and give rise to oligodendrocytes and astrocytes. Cortical injury
enhances progenitor cell expansion and differentiation. In vitro
analysis: 1. To define the cellular properties of epidermal growth
factor-responsive cortical multipotent progenitors and their progeny:
A. Do these progenitors undergo long-term self-renewal? B. What is
the composition of neural lineage species derived from these multipotent
cells? C. What are the cellular actions of neurotrophin-3 on
oligodendroglial and astroglial development from glial progenitors
derived from these multipotent cells? In vivo analysis: 2. To define
the presence of appropriate early postnatal microenvironmental signals
for cortical progenitor cell development: A. Are the cellular profiles
of progenitor expansion, lineage restriction and differentiation
equivalent in vitro and in vivo? B. Are glial-restricted progeny
bipotent in vivo? C. Do different areas of the CNS neuraxis promote
distinct progenitor cell response profiles?
These studies will further our understanding of early progenitor cell
regulatory events in neural lineage development during normal mammalian
cerebral cortical maturation, identify pathologic mechanisms underlying
a range of genetic and acquired neurologic disorders, and promote the
development of novel regenerative strategies.
我们从大脑皮层中分离出了多能祖细胞
在高峰期不依赖于室周生成区
出生后早期胶质细胞的形成 这些祖先物种经历了
细胞增殖和自我更新在体外响应表皮
生长因子,可以产生神经元和神经胶质,包括髓鞘
表达蛋白质的少突胶质细胞。胶质祖细胞来源于
这些多能祖细胞表达神经营养素-3受体,trkC,
神经营养素-3的应用选择性地促进了
少突胶质细胞祖细胞需要额外的环境
信号(睫状神经营养因子,CNTF)的少突胶质细胞
分化 神经营养素-3还可以诱导
皮层神经胶质祖细胞上的CNTF α受体
多能细胞,而骨形态发生蛋白则促进多能细胞
星形胶质细胞的产生并诱导这些细胞上trkC的表达
祖先物种 在初步的体内研究中,我们还表明,
移植的皮层多能细胞可以经历细胞
扩增并产生神经胶质和神经元后代。 此外,本发明还提供了一种方法,
从这些多能细胞中分离的神经胶质祖细胞增殖,
体内并产生少突胶质细胞和星形胶质细胞。 皮层损伤
增强祖细胞扩增和分化。体外
分析:1.来定义表皮生长的细胞特性
因子响应性皮质多能祖细胞及其后代:
A. 这些祖细胞会进行长期的自我更新吗? B。 是什么
神经谱系物种的组成来源于这些多能
细胞? C. 神经营养素-3在细胞内的作用是什么?
少突胶质细胞和星形胶质细胞从胶质祖细胞发育
从这些多能细胞中提取的体内分析:2. 以限定
适当的早期出生后微环境信号的存在
皮质祖细胞发育:A. 是细胞分布图
祖先的扩张,谱系的限制和分化
体外和体内等效? B。 是胶质细胞限制的后代
体内双能性 C. 中枢神经系统轴突的不同区域
不同的祖细胞反应谱
这些研究将进一步加深我们对早期祖细胞
正常哺乳动物神经谱系发育中的调节事件
大脑皮层成熟,确定病理机制,
一系列遗传性和获得性神经系统疾病,并促进
开发新的再生策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark F Mehler其他文献
Mark F Mehler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark F Mehler', 18)}}的其他基金
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
Development of a conditional inducible Huntington’s disease murine model to study complex pathogenic mechanisms
开发条件诱导亨廷顿病小鼠模型以研究复杂的致病机制
- 批准号:
10352824 - 财政年份:2021
- 资助金额:
$ 29.61万 - 项目类别:
Huntington's disease: a novel developmental oligodendrogliopathy
亨廷顿病:一种新型的发育性少突胶质细胞病
- 批准号:
9079941 - 财政年份:2016
- 资助金额:
$ 29.61万 - 项目类别:
Huntington's disease: a novel developmental oligodendrogliopathy
亨廷顿病:一种新型的发育性少突胶质细胞病
- 批准号:
9233213 - 财政年份:2016
- 资助金额:
$ 29.61万 - 项目类别:
Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?
神经退行性疾病:一类新的原发性发育障碍?
- 批准号:
7994651 - 财政年份:2010
- 资助金额:
$ 29.61万 - 项目类别:
Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?
神经退行性疾病:一类新的原发性发育障碍?
- 批准号:
9131845 - 财政年份:2010
- 资助金额:
$ 29.61万 - 项目类别:
Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?
神经退行性疾病:一类新的原发性发育障碍?
- 批准号:
8478219 - 财政年份:2010
- 资助金额:
$ 29.61万 - 项目类别:
Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?
神经退行性疾病:一类新的原发性发育障碍?
- 批准号:
8269914 - 财政年份:2010
- 资助金额:
$ 29.61万 - 项目类别:
Neurodegenerative Diseases: A New Class of Primary Developmental Disorders?
神经退行性疾病:一类新的原发性发育障碍?
- 批准号:
8117100 - 财政年份:2010
- 资助金额:
$ 29.61万 - 项目类别:
相似海外基金
Hedgehog signalling in T-cell differentiation and function
T 细胞分化和功能中的 Hedgehog 信号传导
- 批准号:
BB/Y003454/1 - 财政年份:2024
- 资助金额:
$ 29.61万 - 项目类别:
Research Grant
Comparative single-cell analysis of disease-derived stem cells to identify the cell fate defect on the cell differentiation trajectory
对疾病来源的干细胞进行比较单细胞分析,以确定细胞分化轨迹上的细胞命运缺陷
- 批准号:
23H02466 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of cell differentiation in colorectal cancer progression
细胞分化在结直肠癌进展中的作用
- 批准号:
23K06661 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dissecting the role of hypoxia in T cell differentiation in cancer
剖析缺氧在癌症 T 细胞分化中的作用
- 批准号:
10578000 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Mechanisms mediating human enteroendocrine cell differentiation and function
介导人肠内分泌细胞分化和功能的机制
- 批准号:
10739834 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
- 批准号:
10586679 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Elucidation of molecular mechanisms of immune cell differentiation of a novel Rab protein in hematopoietic stem cells
阐明造血干细胞中新型Rab蛋白免疫细胞分化的分子机制
- 批准号:
23K16122 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New strategies in cell replacement therapies for diabetes: role of USP7 in iPSC and adult organoids beta cell differentiation
糖尿病细胞替代疗法的新策略:USP7 在 iPSC 和成体类器官 β 细胞分化中的作用
- 批准号:
MR/X01813X/1 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Research Grant
Role of alveolar fibroblasts in extracellular matrix organization and alveolar type 1 cell differentiation
肺泡成纤维细胞在细胞外基质组织和肺泡1型细胞分化中的作用
- 批准号:
10731854 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Exhaustive Identification of Essential Genes for Human Taste Cell Differentiation ~Development of a Method for Inducing Differentiation of Taste Buds from ES/iPS Cells~
彻底鉴定人类味觉细胞分化必需基因~开发诱导ES/iPS细胞味蕾分化的方法~
- 批准号:
23K09214 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)